As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
On Monday, Merrimack Pharmaceuticals (NASDAQ:MACK)'s Director, Michael E. Porter, made a $221,548 purchase of MACK, buying 32,390 shares at a cost of $6.84 a piece. Porter was up about 7.3% on the buy at the high point of today's trading session, with MACK trading as high as $7.34 in trading on Tuesday. Merrimack Pharmaceuticals is trading up about 5.5% on the day Tuesday. Before this latest buy, Porter bought MACK on 8 other occasions during the past twelve months, for a total cost of $1.07M at an average of $4.50 per share.
And on Tuesday, CEO & President John T. Rynd bought $144,360 worth of Hercules Offshore (HERO), buying 36,000 shares at a cost of $4.01 a piece. This buy marks the first one filed by Rynd in the past year. Hercules Offshore is trading off about 1% on the day Tuesday.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.